The recent study by Zhang et al. demonstrated that in vivo administration of the microtubule stabilizer Paxceed prevented tau sequestration and improved axonal transport in a mouse model of tauopathy, providing the first indication that compounds affecting microtubule integrity might have therapeutic potential for neurodegenerative diseases involving tau [30]. Here, MAPT is linked to neurodegenerative disease.